June 11, 2019

eStar updates for prescriptions with temporary names and allergy review

New alert for prescriptions with temporary names

Beginning June 12, a new alert will notify clinicians to use a patient’s legal name for prescriptions sent to outpatient pharmacies. The alert will appear if a clinician attempts to send a prescription to an outpatient pharmacy for a patient with a temporary name (e.g., STAT, Baby Boy, etc.) in eStar. Outpatient pharmacies cannot, by law, fill prescriptions without a patient’s legal name.

To send the prescription, the clinician may:

  • Complete Request for Correction or Change to Core Patient Identifiers form to update the patient’s name in the chart
  • Phone in the prescription using patient’s legal name
  • Manually write the prescription using patient’s legal name

For more information, refer to Tip Sheet “Writing Prescriptions for Patients with Temporary Names” in Hubbl.

New functionality for Allergy Review BPA

Beginning June 12, new functionality in the inpatient allergy review best practice advisory (BPA) will appear. The functionality will allow clinicians to review allergies and mark them as reviewed directly within the BPA, streamlining their workflow.

Previously, the allergies review BPA required clinicians to leave their current workflow and go to a separate activity to review allergies. The new functionality allows for in-BPA review.

If the patient has allergies on file (including “No Known Allergies”) which haven’t been reviewed in current encounter:

  • BPA will now display tabular view of the allergies
  • Choosing “Mark allergies as reviewed” will actually mark allergies as reviewed for the current encounter in eStar (without making the clinician go to the Allergy activity)

If a patient has no allergies on file:

  • Choosing “No known allergies” will document that the patient has no known allergies within eStar and will actually mark allergies as reviewed for the current encounter in eStar (without making the clinician go to the Allergy activity)

In both scenarios:

  • Clicking the hyperlink will now take the clinician to Allergies activity to view / add / edit allergies
  • Choosing “Unable to assess allergies” will delay BPA for the current user for 24 hours